148 related articles for article (PubMed ID: 32936997)
1. Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study.
Fanning L; Wong ICK; Li X; Chan EW; Mongkhon P; Man KKC; Wei L; Leung WK; Darzins P; Bell JS; Ilomaki J; Lau WCY
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1550-1561. PubMed ID: 32936997
[TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
Lee SR; Kwon S; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
Cardiovasc Drugs Ther; 2022 Aug; 36(4):679-689. PubMed ID: 33730289
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants : A Nationwide Propensity Score-Weighted Study.
Ingason AB; Hreinsson JP; Ágústsson AS; Lund SH; Rumba E; Pálsson DA; Reynisson IE; Guðmundsdóttir BR; Önundarson PT; Björnsson ES
Ann Intern Med; 2021 Nov; 174(11):1493-1502. PubMed ID: 34633836
[TBL] [Abstract][Full Text] [Related]
5. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Tapaskar N; Ham SA; Micic D; Sengupta N
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis.
Yang KT; Sun WC; Tsai TJ; Tsay FW; Chen WC; Cheng JS
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375495
[No Abstract] [Full Text] [Related]
10. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339
[TBL] [Abstract][Full Text] [Related]
11. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry).
Wong JM; Maddox TM; Kennedy K; Shaw RE
Am J Cardiol; 2020 May; 125(10):1500-1507. PubMed ID: 32276760
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
[TBL] [Abstract][Full Text] [Related]
13. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM
Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care.
Gorst-Rasmussen A; Lip GY; Bjerregaard Larsen T
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1236-1244. PubMed ID: 27229855
[TBL] [Abstract][Full Text] [Related]
15. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA
Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551
[TBL] [Abstract][Full Text] [Related]
16. Frequency, Trend, Predictors, and Impact of Gastrointestinal Bleeding in Atrial Fibrillation Hospitalizations.
Dave M; Kumar A; Majmundar M; Adalja D; Shariff M; Shah P; Desai R; Patel K; Jagirdhar GSK; Vallabhajosyula S; Gullapalli N; Doshi R
Am J Cardiol; 2021 May; 146():29-35. PubMed ID: 33529616
[TBL] [Abstract][Full Text] [Related]
17. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
He Y; Wong IC; Li X; Anand S; Leung WK; Siu CW; Chan EW
Br J Clin Pharmacol; 2016 Jul; 82(1):285-300. PubMed ID: 26889922
[TBL] [Abstract][Full Text] [Related]
18. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Valanejad SM; Davis KA; Nisly SA
Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
[TBL] [Abstract][Full Text] [Related]
20. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong IC; Leung WK
Gut; 2020 Mar; 69(3):445-452. PubMed ID: 31101690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
